z-logo
open-access-imgOpen Access
Increased cGAS/STING signaling components in patients with Mooren’s ulcer
Author(s) -
Yani Zhang,
Yanling Dong,
Wenpei Hao,
Xiaofei Bai,
Xia Qi,
Ting Liu,
Xiaotong Sun,
Chao Wei,
Xiaolin Qi
Publication year - 2021
Publication title -
international journal of ophthalmology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.634
H-Index - 29
eISSN - 2227-4898
pISSN - 2222-3959
DOI - 10.18240/ijo.2021.11.03
Subject(s) - irf3 , sting , western blot , immunohistochemistry , medicine , interferon , signal transduction , phosphorylation , blot , microbiology and biotechnology , cxcl10 , innate immune system , immunology , immune system , biology , chemokine , gene , biochemistry , engineering , aerospace engineering
AIM: To explore the expression of cGAS/STING signaling components in Mooren’s ulcer (MU).METHODS: Samples were obtained from ten MU patients, and eight residual corneal-scleral rings of healthy donor corneas for controls. Human corneal epithelial cells (HCECs) were used to evaluate the effect of cGAS/STING signaling pathway. Immunohistochemistry (IHC) and Western blot were used to examine the expression of cGAS, STING, and phosphorylated interferon regulatory factor 3 (p-IRF3) in MU tissues. The expression of interferon-β (IFN-β) and interferon-stimulated genes (ISGs) was quantified by real-time polymerase chain reaction (PCR) and enzyme-linked immunosorbent assay (ELISA).RESULTS: The protein levels of cGAS and STING in MU samples were significantly elevated when compared with the healthy controls by Western blot and IHC. After stimulation with cGAMP, real-time PCR and ELISA showed a dramatic increase of IFN-β and ISGs (containing CXCL10, IFIT1, and IL-6) in HCECs. Moreover, HCECs treated with cGAMP was characterized by increased phosphorylation and more nuclear translocation of IRF3. Meanwhile, increased p-IRF3 was observed in MU samples via IHC and Western blot.CONCLUSION: The pronounced expression of cGAS/STING signaling components in the patients with MU and probably contribute to the onset and development of MU.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here